申请人:Takeda Chemical Industries, Ltd.
公开号:US03969409A1
公开(公告)日:1976-07-13
Novel cyclohexenone derivatives, which are shown by the general formula ##SPC1## Wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, lower alkyl or phenyl group; one of R.sup.3 and R.sup.4 represents a hydrogen atom or lower alkyl group, and the other represents an unsubstituted or substituted phenyl, lower alkyl or aralkyl group, or R.sup.3 and R.sup.4, taken together with the adjacent nitrogen atom, form a 5 to 6-membered heterocyclic ring; one of R.sup.5 and R.sup.6 represents a hydrogen atom or lower alkyl group, and the other represents a lower alkyl, phenyl or aralkyl group, or R.sup.5 and R.sup.6, taken together with the adjacent nitrogen atom, form an unsubstituted or substituted 5 to 6-membered heterocyclic ring, and their pharmaceutically acceptable salts, useful medicines such as analgesics.
新型环己烯酮衍生物,其通式如##SPC1##所示,其中R1和R2各自代表氢原子、低级烷基或苯基;R3和R4中之一代表氢原子或低级烷基,另一代表未取代或取代的苯基、低级烷基或芳烷基,或者R3和R4与相邻的氮原子一起形成5至6元杂环;R5和R6中之一代表氢原子或低级烷基,另一代表低级烷基、苯基或芳烷基,或者R5和R6与相邻的氮原子一起形成未取代或取代的5至6元杂环,及其药用可接受的盐,作为止痛药等有用药物。